Home
/ Serum Institute of India

Serum Institute of India

Serum Institute of India

Serum Institute of India Summary

Company summary

Overview: Serum Institute of India is a biotechnology company. It produces and develops immunobiological drugs and vaccines for polio, diphtheria, tetanus, pertussis, Hib, BCG, r-hepatitis b, measles, mumps, and rubella diseases.

Type: Subsidiary

Status: Active

Founded: 1966

HQ: Pune, IN | view all locations

Website: https://www.seruminstitute.com

Cybersecurity rating

Sectors

Key people

Cyrus S. Poonawalla, Chairman and Managing Director
Adar C. Poonawalla, CEO

LocationsView all

3 locations detected

Pune, MH HQ
India
212, 2, Hadapsar Bridge, Hadapsar Gaon, Hadapsar
Mumbai, MH
India
211, Free Press Journal Marg, Nariman Point
Pune, MH
India
Dr Baba Saheb Ambedkar Rd, Camp

Competitors and similar companies

Compare competitors

News

GreenLight Biosciences Holdings, PBC (GRNA) enters into multitarget licensing agreement with Serum Institute of India to develop and commercialize messenger RNA products for emerging markets globally

Mar 14, 2022

India Pharmaceutical Market Assessment Report 2021-2022 Featuring Bharat Biotech International, Serum Institute of India, Dr. Reddy's Laboratories, Sun Pharma Industries, & Cipla Ltd

Feb 15, 2022

Serum Institute of India to begin Sputnik V manufacturing from September: RDIF

Jul 13, 2021

RDIF and Serum Institute of India, the world's largest vaccine manufacturer by volume, to start production of Sputnik vaccine at Company's facilities in September

Jul 13, 2021